William Z. Zhang

William Z. Zhang

Auto-generated profile, based on publicly available information

William Z. Zhang

Joan and Sanford I. Weill Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
WZWilliam Z. Zhang
William Z. Zhang
MRMichelle C. Rice
Michelle C. Rice
KHKatherine L. Hoffman
Katherine L. Hoffman
COClara Oromendia
Clara Oromendia
IBIgor Barjaktarevic
Igor Barjaktarevic
MCMary E. Choi
Mary E. Choi
BACKGROUND: Mitochondrial dysfunction, a proposed mechanism of chronic obstructive pulmonary disease (COPD) pathogenesis, is associated with the leakage of mitochondrial DNA (mtDNA), which may be detected extracellularly in various bodily fluids. Despite evidence for the increased prevalence of chronic kidney disease in COPD subjects and for mitochondrial dysfunction in the kidneys of murine COPD models, whether urine mtDNA (u-mtDNA) associates with measures of disease severity in COPD is unknown. METHODS: Cell-free u-mtDNA, defined as copy number of mitochondrially encoded NADH dehydrogenase-1 ( MTND1 ) gene, was measured by quantitative PCR and normalized to urine creatinine in cell-free urine samples from participants in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort. Urine albumin/creatinine ratios (UACR) were measured in the same samples. Associations between u-mtDNA, UACR, and clinical disease parameters — including FEV 1 % predicted, clinical measures of exercise tolerance, respiratory symptom burden, and chest CT measures of lung structure — were examined. RESULTS: U-mtDNA and UACR levels were measured in never smokers ( n = 63), smokers without airflow obstruction ( n = 107), participants with mild/moderate COPD ( n = 139), and participants with severe COPD ( n = 166). U-mtDNA was associated with increased respiratory symptom burden, especially among smokers without COPD. Significant sex differences in u-mtDNA levels were observed, with females having higher u-mtDNA levels across all study subgroups. U-mtDNA associated with worse spirometry and CT emphysema in males only and with worse respiratory symptoms in females only. Similar associations were not found with UACR. CONCLUSION: U-mtDNA levels may help to identify distinct clinical phenotypes and underlying pathobiological differences in males versus females with COPD. TRIAL REGISTRATION: This study has been registered at ClinicalTrials.gov ( NCT01969344). FUNDING: US NIH, National Heart, Lung and Blood Institute, supplemented by contributions made through the Foundation for the NIH and the COPD Foundation from AstraZeneca/MedImmune, Bayer, Bellerophon Therapeutics, Boehringer-Ingelheim Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Forest Research Institute Inc., GlaxoSmithKline, Grifols Therapeutics Inc., Ikaria Inc., Novartis Pharmaceuticals Corporation, Nycomed GmbH, ProterixBio, Regeneron Pharmaceuticals Inc., Sanofi, Sunovion, Takeda Pharmaceutical Company, and Theravance Biopharma and Mylan.

1 May 2023 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
MSMays Mohammed Salih
Mays Mohammed Salih
ERElektra Kantzari Robinson
Elektra Kantzari Robinson
EMEric Malekos
Eric Malekos
EPElizabeth Perez
Elizabeth Perez
ACAllyson Capili
Allyson Capili
SCSusan Carpenter
Susan Carpenter
Cigarette smoke (CS) exposure is a risk factor for many chronic diseases, including chronic obstructive pulmonary disease, but the mechanism by which smoke exposure can alter homeostasis and bring about chronic inflammation is poorly understood. Here, we showcase a novel role for smoke in regulating long noncoding RNAs, showing that it activates lincRNA-Cox2, which we previously characterized as functional in inflammatory regulation. Exposing lincRNA-Cox2 murine models to smoke in vivo confirmed lincRNA-Cox2 as a regulator of inflammatory gene expression in response to smoke both systemically and within the lung. We also report that lincRNA-Cox2 negatively regulates genes in smoked bone marrow–derived macrophages exposed to LPS stimulation. In addition to the effects on long noncoding RNAs, we also report dysregulated transcription and splicing of inflammatory protein-coding genes in the bone marrow niche after CS exposure in vivo. Collectively, this work provides insights into how innate immune signaling from gene expression to splicing is altered after in vivo exposure to CS and highlights an important new role for lincRNA-Cox2 in regulating immune genes after smoke exposure.

1 April 2023 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
KKKihwan Kim
Kihwan Kim
WZWilliam Z. Zhang
William Z. Zhang
SKSarah Ann Kikkers
Sarah Ann Kikkers
SOSarah L. O’bEirne
Sarah L. O’bEirne
YSYael Strulovici-Barel
Yael Strulovici-Barel
SCSuzanne M. Cloonan
Suzanne M. Cloonan

1 July 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
WZWilliam Z. Zhang
William Z. Zhang

8 January 2026
Verified
Journal Article
Open access
SCSuzanne Cloonan
Suzanne Cloonan
WZWilliam Zhang
William Zhang
KKKihwan Kim
Kihwan Kim
LFLynne Faherty
Lynne Faherty
WSWill Simmons
Will Simmons
CMCem Meydan
Cem Meydan
Ferritin, consisting of ferritin heavy chain (FTH1) and light chain (FTL) subunits, is an essential intracellular iron storage protein fundamental for cellular function. However, the source and the biological role of extracellular ferritin (ex-ferritin) are less understood. Recent studies have linked elevated serum ex-ferritin with adverse outcomes in individuals with acute respiratory distress syndrome (ARDS). In this study, we demonstrate that both FTH1 and FTL are significantly enriched in the serum, blood monocytes, and alveolar macrophages (AMs) of individuals with ARDS, a phenomenon we successfully replicate in a murine hyperoxia-induced acute lung injury (HALI) model. We show that FTH1 is consistently upregulated in macrophages during lung injury development, and mice with a targeted deletion of FTH1 in myeloid (LysMcre) or resident lung macrophage (Cd11ccre) populations exhibit attenuated HALI. This reduced injury is linked to macrophage resistance to ferroptotic cell death, ferritinophagy, altered airway inflammatory responses, and lower lung extracellular iron and higher levels of FTL-ex-ferritin. Transplantation of FTL-ex-ferritin-enriched bronchoalveolar lavage fluid to wild-type mice protected against HALI. The ratio of FTL-ex-ferritin to FTH1 in the serum of individuals with ARDS who died was higher than that of those that survived, suggesting that the balance between FTH1 and FTL may play a role in injury modulation. Our findings highlight macrophage ferritin as a key regulator of macrophage survival and the response of the lung to injury, presenting a potentially targetable pathway for ARDS treatment.

24 June 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
WZWilliam Z. Zhang
William Z. Zhang
MRMichelle C. Rice
Michelle C. Rice
KHKatherine L. Hoffman
Katherine L. Hoffman
COClara Oromendia
Clara Oromendia
IBIgor Z. Barjaktarevic
Igor Z. Barjaktarevic
MCMary E. Choi
Mary E. Choi